Skip to main navigation
Skip to main content
Skip to Footer

English
- Français

Canada
- Sandoz Site Directory

Our Work
About Us
Products
News
Careers

Search

TwitterTweet
FacebookShare
Share
- Twitter
- Facebook
- LinkedIn
- Email
Jump to Comments

Stories/Global Impact

Global Sandoz Press Release about biosimilar Erelzi®

Nov 19, 2019

To read the Sandoz press release, click here:

https://www.sandoz.com/news/media-releases/sandoz-presents-real-world-data-showing-effectiveness-erelzi-etanercept-szzs

- TwitterTweet
- FacebookShare
- Share
  - Twitter
  - Facebook
  - LinkedIn
  - Email
- Jump to Comments
Print
Save

Novartis Stories

Sandoz Canada completes its 5th biosimilar launch with new biosimilar Hyrimoz® (adalimumab)

Sandoz Canada launches the first generic versions of two original drugs: PrSandoz® Posaconazole and PrSandoz® Silodosin

2021 Top Employer Canada

You are here

Home ›
Global Impact ›

Sandoz Canada

Our Work
About Us
Products
News
Careers
Contact Us
Office Locations
Stay up to date

Subscribe to Sandoz

Facebook
Twitter
YouTube
LinkedIn
RSS

Sandoz Site Directory

© 2021 Sandoz AG

This site is intended for an audience in Canada

Terms of Use
Privacy Policy
Terms of Trade
Return Policy